ChartMill assigns a Buy % Consensus number of 82% to ATOS. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-22 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-06-05 | Craig-Hallum | Initiate | Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-03-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-09 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-06 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-05-14 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-12 | HC Wainwright & Co. | Initiate | Buy |
| 2023-09-08 | Cantor Fitzgerald | Initiate | Overweight |
10 analysts have analysed ATOS and the average price target is 5.8 USD. This implies a price increase of 643.75% is expected in the next year compared to the current price of 0.78.
The consensus rating for ATOSSA THERAPEUTICS INC (ATOS) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ATOSSA THERAPEUTICS INC (ATOS) is 10.